Skip to menu Skip to content Skip to footer
Dr Jodi Saunus
Dr

Jodi Saunus

Email: 

Overview

Background

Dr Jodi Saunus is a senior fellow who specialises in translational research on metastatic breast cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to help facilitate patient-focused research at the interface of biomedical R&D and clinical practice.

Dr Saunus has an honours degree in biochemistry and biomedical science, a PhD in breast cancer molecular genetics, and broad post-doctoral experience in immunology, molecular cell biology, pathology informatics, and early-phase investigator-initiated clinical trials. Her current portfolio focuses finding new ways to improve the clinical management of aggressive breast cancer, with a focus on triple-negative breast cancer, and the prevention and treatment of brain metastases. This work spans across multiple disciplines and capabilities, and broadly involves:

  • Molecular profiling of patient-donated blood and tumour tissue samples to identify features that can predict treatment response, or represent previously uncharacterised therapeutic targets.
  • Using experimental models of breast cancer metastasis to learn about the molecular mechanisms exploited by cancer cells to survive and grow in brain tissue.
  • Developing innovative treatment strategies that work differently to conventional cancer drugs, including alpha-particle endoradiotherapy and in-situ vaccination.

With an outstanding network of collaborators from academia and clinical practice, she has secured more than $6M to fund this work and has a track record of publishing in prominent biomedical research journals (e.g., Cancer Research, Nature, Science Translational Medicine, Nature Communications and The Journal of Pathology).

Peripherally, Jodi is a strong proponent of biospecimen banking, and clinician and consumer engagement in translational research.

Availability

Dr Jodi Saunus is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • Biomarkers of triple-negative breast cancer progression and response to therapy

    Using published datasets, and tissue donated by Brisbane breast cancer patients, we're trying to identify new biomarkers of prognosis and treatment response in breast cancer.

  • Understanding how the triple-negative breast cancer transcriptome is rewired during tumour progression

    We apply mathematical approaches to analyse transcriptional networks in TNBC, illuminating how cell biology evolves during tumour development and post-treatment relapse.

  • Understanding the brain metastasis immune microenvironment

    In collaboration with immuno-oncology experts at the Peter MacCallum Cancer Centre in Melbourne, we are studying the expression of common tumour antigens to develop strategies for vaccination against cancer.

  • Therapeutic antibody uptake in brain metastases

    Brain metastases are broadly refractory to existing systemic therapies. We believe that abnormal vascular function and interstitial fluid dynamics in these tumours may contribute more than previously appreciated. We aim to engineer molecular-targeted carriers that improve the effectiveness and reduce the side-effects of radiotherapy and chemotherapy.

Works

Search Professor Jodi Saunus’s works on UQ eSpace

104 works between 2002 and 2025

21 - 40 of 104 works

2021

Journal Article

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Johnson, Nichola, Maguire, Sarah, Morra, Anna, Kapoor, Pooja Middha, Tomczyk, Katarzyna, Jones, Michael E., Schoemaker, Minouk J., Gilham, Clare, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Ahearn, Thomas U., Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arndt, Volker, Aronson, Kristan J., Augustinsson, Annelie, Baynes, Caroline, Freeman, Laura E. Beane, Beckmann, Matthias W., Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Boeckx, Bram, Bogdanova, Natalia V., Bojesen, Stig E., Brauch, Hiltrud, Brenner, Hermann ... Fletcher, Olivia (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4), 842-854. doi: 10.1038/s41416-020-01185-w

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

2020

Journal Article

Breast cancer polygenic risk score and contralateral breast cancer risk

Kramer, Iris, Hooning, Maartje J., Mavaddat, Nasim, Hauptmann, Michael, Keeman, Renske, Steyerberg, Ewout W., Giardiello, Daniele, Antoniou, Antonis C., Pharoah, Paul D.P., Canisius, Sander, Abu-Ful, Zumuruda, Andrulis, Irene L., Anton-Culver, Hoda, Aronson, Kristan J., Augustinsson, Annelie, Becher, Heiko, Beckmann, Matthias W., Behrens, Sabine, Benitez, Javier, Bermisheva, Marina, Bogdanova, Natalia V., Bojesen, Stig E., Bolla, Manjeet K., Bonanni, Bernardo, Brauch, Hiltrud, Bremer, Michael, Brucker, Sara Y., Burwinkel, Barbara, Castelao, Jose E. ... Schmidt, Marjanka K. (2020). Breast cancer polygenic risk score and contralateral breast cancer risk. American Journal of Human Genetics, 107 (5), 837-848. doi: 10.1016/j.ajhg.2020.09.001

Breast cancer polygenic risk score and contralateral breast cancer risk

2020

Journal Article

Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1

Kalaw, Emarene, Lim, Malcolm, Kutasovic, Jamie R., Sokolova, Anna, Taege, Lucinda, Johnstone, Kate, Bennett, James, Saunus, Jodi M., Niland, Colleen, Ferguson, Kaltin, Gresshoff, Irma, Bettington, Mark, Pathmanathan, Nirmala, Tse, Gary M., Papadimos, David, Pathmanathan, Rajadurai, Harris, Gavin, Yamaguchi, Rin, Tan, Puay Hoon, Fox, Stephen, O’Toole, Sandra A., Simpson, Peter T., Lakhani, Sunil R. and McCart Reed, Amy E. (2020). Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1. British Journal of Cancer, 123 (11), 1665-1672. doi: 10.1038/s41416-020-01065-3

Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1

2020

Journal Article

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases

Kalita-de Croft, Priyakshi, Lim, Malcolm, Chittoory, Haarika, de Luca, Xavier M., Kutasovic, Jamie R., Day, Bryan W., Al-Ejeh, Fares, Simpson, Peter T., McCart Reed, Amy E., Lakhani, Sunil R. and Saunus, Jodi M. (2020). Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases. Therapeutic Advances in Medical Oncology, 12 1758835920946259, 175883592094625. doi: 10.1177/1758835920946259

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases

2020

Journal Article

Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer

Abdel-Fatah, Tarek M. A., Ball, Graham R., Thangavelu, Pulari U., Reid, Lynne E., McCart Reed, Amy E., Saunus, Jodi M., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R., Pongor, Lorinc, Gyorffy, Balázs, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Caldas, Carlos, Ellis, Ian O. and Chan, Stephen Y. T. (2020). Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer. JAMA Network Open, 3 (7) e209486, e209486. doi: 10.1001/jamanetworkopen.2020.9486

Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer

2020

Journal Article

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

Zhang, Lin, Yao, Jun, Wei, Yongkun, Zhou, Zhifen, Li, Ping, Qu, Jingkun, Badu-Nkansah, Akosua, Yuan, Xiangliang, Huang, Yu-Wen, Fukumura, Kazutaka, Mao, Xizeng, Chang, Wei-Chao, Saunus, Jodi, Lakhani, Sunil, Huse, Jason T., Hung, Mien-Chie and Yu, Dihua (2020). Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases. Science Translational Medicine, 12 (545) eaaz5387, eaaz5387. doi: 10.1126/scitranslmed.aaz5387

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

2020

Journal Article

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer

Adwal, Alaknanda, Kalita-de Croft, Priyakshi, Shakya, Reshma, Lim, Malcolm, Kalaw, Emarene, Taege, Lucinda D., McCart Reed, Amy E., Lakhani, Sunil R., Callen, David F. and Saunus, Jodi M. (2020). Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer. Life Science Alliance, 3 (7) e201900562, 1-12. doi: 10.26508/lsa.201900562

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer

2020

Other Outputs

Hotspot KRAS mutations in brain metastases at the first metastatic recurrence of cutaneous melanoma

Rabbie, Roy, Ferguson, Peter, Wong, Kim, Moran, Una, Turner, Clinton, Emanuel, Patrick, Haas, Kerstin, Saunus, Jodi M., Davidson, Morgan R., Lakhani, Sunil R., Shivalingam, Brindha, Long, Georgina V., Parkinson, Christine, Osman, Iman, Scolyer, Richard A., Corrie, Pippa and Adams, David J. (2020). Hotspot KRAS mutations in brain metastases at the first metastatic recurrence of cutaneous melanoma. doi: 10.1101/2020.02.17.952630

Hotspot KRAS mutations in brain metastases at the first metastatic recurrence of cutaneous melanoma

2020

Journal Article

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking

Gedye, Craig, Sachchithananthan, Mythily, Leonard, Robyn, Jeffree, Rosalind L., Buckland, Michael E., Ziegler, David S., Graeber, Manuel B., Day, Bryan W., McDonald, Kerrie L., Lasocki, Arian, Back, Michael, Besser, Michael, Boyd, Andrew, Buckland, Michael, Byrne, Jennifer, Cher, Lawrence, Cook, Raymond, Day, Bryan, Day, Jerry, Davidson, Andrew, Devereux, Lisa, Dexter, Mark, Donnelly, Roy, Drummond, Kate, Eckstein, Lisa, Gan, Hui, Garrick, Therese, Gedye, Craig, Gottardo, Nick ... Nowak, Anna K (2020). Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking. Neuro-Oncology Practice, 7 (1), 31-37. doi: 10.1093/nop/npz036

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking

2020

Journal Article

Non-coding RNAs underlie genetic predisposition to breast cancer

Moradi Marjaneh, Mahdi, Beesley, Jonathan, O'Mara, Tracy A., Mukhopadhyay, Pamela, Koufariotis, Lambros T., Kazakoff, Stephen, Hussein, Nehal, Fachal, Laura, Bartonicek, Nenad, Hillman, Kristine M., Kaufmann, Susanne, Sivakumaran, Haran, Smart, Chanel E., McCart Reed, Amy E., Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., Barnes, Daniel R., Antoniou, Antonis C., Dinger, Marcel E., Waddell, Nicola, Easton, Douglas F., Dunning, Alison M., Chenevix-Trench, Georgia, Edwards, Stacey L. and French, Juliet D. (2020). Non-coding RNAs underlie genetic predisposition to breast cancer. Genome Biology, 21 (1) 7, 7. doi: 10.1186/s13059-019-1876-z

Non-coding RNAs underlie genetic predisposition to breast cancer

2020

Conference Publication

Remodelling of calcium influx pathways in breast cancer associated fibroblasts

Sadras, Francisco, Stewart, Teneale A., Robitaille, Melanie, Peters, Amelia A., Kalita-de Croft, Priyakshi, Soon, Patsy, Saunus, Jodi M., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Remodelling of calcium influx pathways in breast cancer associated fibroblasts. 2019 San Antonio Breast Cancer Symposium, San Antonio, TX United States, 10-14 December 2019. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.sabcs19-p6-06-15

Remodelling of calcium influx pathways in breast cancer associated fibroblasts

2020

Journal Article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Fachal, Laura, Aschard, Hugues, Beesley, Jonathan, Barnes, Daniel R., Allen, Jamie, Kar, Siddhartha, Pooley, Karen A., Dennis, Joe, Michailidou, Kyriaki, Turman, Constance, Soucy, Penny, Lemaçon, Audrey, Lush, Michael, Tyrer, Jonathan P., Ghoussaini, Maya, Marjaneh, Mahdi Moradi, Jiang, Xia, Agata, Simona, Aittomäki, Kristiina, Alonso, M. Rosario, Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arason, Adalgeir, Arndt, Volker, Aronson, Kristan J., Arun, Banu K., Auber, Bernd, Auer, Paul L. ... Dunning, Alison M. (2020). Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1), 56-73. doi: 10.1038/s41588-019-0537-1

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

2020

Conference Publication

Calcium communication in an in vitro model of breast cancer brain metastases

Chalmers, Silke B., Sadras, Francisco, Saunus, Jodi , Lakhani, Sunil , Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Calcium communication in an in vitro model of breast cancer brain metastases. ASCEPT-APSA Joint virtual scientific meeting 2020, Virtual meeting, 24-26 November 2020.

Calcium communication in an in vitro model of breast cancer brain metastases

2019

Journal Article

Calcium signalling and breast cancer

So, Choon Leng, Saunus, Jodi M., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2019). Calcium signalling and breast cancer. Seminars in Cell & Developmental Biology, 94, 74-83. doi: 10.1016/j.semcdb.2018.11.001

Calcium signalling and breast cancer

2019

Journal Article

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

McCart Reed, Amy E., Lal, Samir, Kutasovic, Jamie R., Wockner, Leesa, Robertson, Alan, de Luca, Xavier M., Kalita-de Croft, Priyakshi, Dalley, Andrew J., Coorey, Craig P., Kuo, Luyu, Ferguson, Kaltin, Niland, Colleen, Miller, Gregory, Johnson, Julie, Reid, Lynne E., Males, Renique, Saunus, Jodi M., Chenevix-Trench, Georgia, Coin, Lachlan, Lakhani, Sunil R. and Simpson, Peter T. (2019). LobSig is a multigene predictor of outcome in invasive lobular carcinoma. npj Breast Cancer, 5 (1) 18, 18. doi: 10.1038/s41523-019-0113-y

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

2019

Journal Article

Proteomic analysis of the breast cancer brain metastasis microenvironment

Kalita-de Croft, Priyakshi, Straube, Jasmin, Lim, Malcolm, Al-Ejeh, Fares, Lakhani, Sunil R. and Saunus, Jodi M. (2019). Proteomic analysis of the breast cancer brain metastasis microenvironment. International Journal of Molecular Sciences, 20 (10) 2524, 2524. doi: 10.3390/ijms20102524

Proteomic analysis of the breast cancer brain metastasis microenvironment

2019

Journal Article

Innovative therapeutic strategies for effective treatment of brain metastases

Lim, Malcolm, Puttick, Simon, Houston, Zachary H., Thurecht, Kristofer J., Kalita-de Croft, Priyakshi, Mahler, Stephen, Rose, Stephen E., Jeffree, Rosalind L., Mazzieri, Roberta, Dolcetti, Riccardo, Lakhani, Sunil R. and Saunus, Jodi M. (2019). Innovative therapeutic strategies for effective treatment of brain metastases. International Journal of Molecular Sciences, 20 (6) 1280, 1280. doi: 10.3390/ijms20061280

Innovative therapeutic strategies for effective treatment of brain metastases

2019

Journal Article

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer

Wiegmans, Adrian P., Saunus, Jodi M., Ham, Sunyoung, Lobb, Richard J., Kutasovic, Jamie R., Dalley, Andrew J., Miranda, Mariska, Atkinson, Caroline, Foliaki, Simote T., Ferguson, Kaltin, Niland, Colleen, Johnstone, Cameron N., Lewis, Victoria, Collins, Steven, Lakhani, Sunil R., Al-Ejeh, Fares and Möller, Andreas (2019). Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer. JCI Insight, 5 (6) e124092. doi: 10.1172/jci.insight.124092

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer

2019

Journal Article

Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications

McCart Reed, Amy Ellen, Kalaw, Emarene, Nones, Katia, Bettington, Mark, Lim, Malcolm, Bennett, James, Johnstone, Kate, Kutasovic, Jamie Rose, Saunus, Jodi Marie, Kazakoff, Stephen, Xu, Qinying, Wood, Scott, Holmes, Oliver, Leonard, Conrad, Reid, Lynne Estelle, Black, Debra, Niland, Colleen, Ferguson, Kaltin, Gresshoff, Irma, Raghavendra, Ashwini, Harvey, Kate, Cooper, Caroline, Liu, Cheng, Kalinowski, Lauren, Reid, Andrew Scott, Davidson, Morgan, Pearson, John V, Pathmanathan, Nirmala, Tse, Gary ... Lakhani, Sunil R. (2019). Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications. Journal of Pathology, 247 (2), 214-227. doi: 10.1002/path.5184

Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications

2019

Conference Publication

Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohort

Reed, A. E. McCart, Kalaw, E., Nones, K., Bettington, M., Lim, M., Bennett, J., Johnstone, K., Kutasovic, J. R., Kazakoff, S., Xu, Q. C., Saunus, J. M., Reid, L. E., Black, D., Niland, C., Ferguson, K., Gresshoff, I., Raghavendra, A., Liu, J. C., Kalinowski, L., Reid, A. S., Davidson, M., Pearson, J. V., Yamaguchi, R., Harris, G., Tse, G., Papadimos, D., Pathmanathan, R., Pathmanathan, N., Tan, P. H. ... Lakhani, S. R. (2019). Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohort. San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P3-08-03

Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohort

Funding

Current funding

  • 2023 - 2028
    ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
    ARC Industrial Transformation Research Hubs
    Open grant

Past funding

  • 2021 - 2023
    ACRF Facility for Targeted Radiometals in Cancer (AFTRiC)
    Australian Cancer Research Foundation
    Open grant
  • 2020
    Identification and validation of novel classes of clinically relevant CD8 tumour antigens for cancer vaccination: supporting translational pipeline feasibility
    PA Research Foundation
    Open grant
  • 2020 - 2021
    New immunotherapeutic options for triple negative and brain metastatic breast cancer: next generation cancer vaccines exploiting new classes of tumour antigens
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2019 - 2021
    Nanomedicine strategies for early detection and treatment of brain metastases
    NHMRC Project Grant
    Open grant
  • 2017 - 2021
    Exploiting the Remodeling of Ca2+ Signaling in Breast Cancer Cell Microenvironments to Control Metastasis and to Specifically Target Brain Metastases
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2015 - 2016
    Repurposing pertuzumab for adjuvant treatment of breast cancer patients with HER2-positive brain metastases
    ANZBCTG Discretionary Funding - Research Seed Funding
    Open grant
  • 2014 - 2015
    The Brisbane Breast Bank
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2013 - 2015
    Prospective study of breast cancer progression by content analysis of circulating exosomes in serially collected blood samples
    Royal Brisbane and Women's Hospital
    Open grant
  • 2010
    Applying Inducible Pluripotent Stem (iPS) Cell Technology to Mammary Biology Research.
    UQ Early Career Researcher
    Open grant
  • 2010
    Isolation of oral epithelial stem cells from normal and dysplastic oral mucosa
    Dental Research Grant Scheme
    Open grant
  • 2010 - 2011
    Molecular validation of autofluorescence and narrow band imaging of oral cancer resection margins
    Dental Research Grant Scheme
    Open grant
  • 2009
    Isolation of Epithelial Stem Cells from Normal and Dysplastic Oral Epithelium.
    Ian Potter Foundation
    Open grant

Supervision

Availability

Dr Jodi Saunus is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Development of new theranostic agents for metastatic breast cancer surveillance and treatment

    Most of the time, treatments for early breast cancer successfully prevent metastatic spread, but 10% of Australian patients still develop lethal recurrences within 5 years. Rather than waiting to see which patients develop symptoms of a possible relapse (e.g., headaches, respiratory symptoms), we are getting better at detecting metastasis early. Patients deemed to be at ‘high risk’ are offered regular PET or MRI scans, allowing earlier intervention and better quality-of-life. PET imaging of radioactive tracers is more specific than MRI, but the standard tracer used in oncology – [18F]fluorodeoxyglucose (FDG) – is not useful for imaging the brain. We are seeking a student to help us develop agents that seek out tumour cells more specifically than FDG and can also be engineered to function as therapeutics. The project is flexible depending on the successful candidate’s expertise and interest (e.g., in vivo models of metastatic breast cancer, protein chemistry and/or molecular biology).

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Dr Jodi Saunus directly for media enquiries about:

  • brain metastases
  • breast cancer
  • metastatic breast cancer
  • stage IV breast cancer

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au